Clinical Trial: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants

U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07136103) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants' on Aug. 15.

Brief Summary: The objective of this study is to evaluate the safety, tolerability, immunogenicity and pharmacokinetics (PK ) properties following a single dose of ABBV-277 in healthy adult participants.

Study Start Date: Aug. 18

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: ABBV-277

* Intravenous (IV) infusion

DRUG: Placebo

* Intravenous (IV) infusion

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AbbVie

Published by HT Digital Content Services with perm...